Spots Global Cancer Trial Database for local consolidation therapy
Every month we try and update this database with for local consolidation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP) | NCT06367972 | OligoProgressiv... | Local Consolida... Next-line Syste... | 18 Years - | M.D. Anderson Cancer Center | |
| Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor | NCT03599765 | Oligometastatic... | Best Practice Local Consolida... | 18 Years - | M.D. Anderson Cancer Center | |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | NCT03707938 | Advanced Lung C... ALK Gene Rearra... Lung Non-Small ... Recurrent Lung ... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Brigatinib Local Consolida... | 18 Years - | M.D. Anderson Cancer Center | |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | NCT03707938 | Advanced Lung C... ALK Gene Rearra... Lung Non-Small ... Recurrent Lung ... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Brigatinib Local Consolida... | 18 Years - | M.D. Anderson Cancer Center | |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | NCT03707938 | Advanced Lung C... ALK Gene Rearra... Lung Non-Small ... Recurrent Lung ... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ... | Brigatinib Local Consolida... | 18 Years - | M.D. Anderson Cancer Center | |
| Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy | NCT04892953 | Stage III Lung ... Stage III Lung ... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Lung... Stage IIIB Lung... Stage IIIC Lung... | Carboplatin Durvalumab Gemcitabine Local Consolida... Nab-paclitaxel Paclitaxel Pemetrexed Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | NCT03391869 | Lung Adenocarci... Lung Non-Small ... Stage IV Lung C... | Ipilimumab Local Consolida... Nivolumab Quality-of-Life... Radiation Thera... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP) | NCT06367972 | OligoProgressiv... | Local Consolida... Next-line Syste... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
